This Company Will Transform The Health Care Industry

The role it will play is indispensable in providing higher quality, ease of access, and affordable care.

The multi-trillion dollar U.S. healthcare market is broken.  The last thing we want to worry about is our health or the higher costs of care. As we emerge from the Covid pandemic, Americans witness a fragmented healthcare system. A lack of coordination results in higher costs and an inefficient allocation of resources. This company will transform the healthcare industry. Its use of Artificial Intelligence (AI) and Machine Learnings (ML) improves health outcomes and reduces costs. It will play an indispensable role in providing higher quality, easily accessible, and affordable care. United States healthcare spending grew 4.6% in 2019 to reach $3.8 trillion or $11,582 per person! Health spending accounts for 17.7% of Gross Domestic Product. Society searches for solutions to reduce these costs and improve treatment. Attention turns to the burgeoning digital health market. Digital health solutions can save the healthcare industry billions of dollars. According to Accenture analysis, key clinical health AI applications can potentially create $150 billion in annual savings for the U.S. healthcare economy by 2026. Adoption of these solutions is evident as the AI health market is expected to reach an incredible compounded annual growth rate of 40%! This company is a leading digital health provider poised to disrupt the traditional healthcare space. The company realigned its business operations to capitalize on AI and ML opportunities. It entered the potential $300 billion global digital health monitoring market by partnering with leading channel partners, health benefit providers, and end-users through a proprietary combination of digital health monitoring devices, AI-based software, and cloud computing platforms.  The company’s solutions are like what Livongo Health offered before it was acquired by Teladoc Health for approximately $18 billion. Livongo used its technology to aggregate data about patients’ chronic conditions and interpret the data to create actionable, personalized, and time-healthy signals. This company’s technology takes it a step further as it includes more automation, limiting humor error.  The company successfully displayed its technology in a project funded by The Bill and Melinda Gates Foundation. This Proof-of-Concept trial helped validate the company’s products and raise M&A interest. This company was selected to participate in several of the foremost U.S.-based Accelerator Programs designed to advance promising digital health technologies. AI continues to put its fingerprint on our daily life. Health is paramount for all of us and AI will allow us to maximize treatments and minimize costs. This company’s AI/ML innovations and services will improve health outcomes. It is the perfect solution for reducing costs on an overburdened healthcare system.  You need to see how this company’s products will help achieve these goals. Read more. Regards, Market News Reports Today This is a PAID ADVERTISEMENT provided to customers of Schaeffer's Investment Research. Although we have sent you this email, Schaeffer's not specifically endorse this product nor is it responsible for the content of this advertisement. Furthermore, we make no guarantee or warranty about what is advertised above. Your privacy is very important to us, if you wish to be excluded from future notices, do not reply to this message. Instead, please click here. DISCLAIMER: In accordance with Section 17(b) of the Securities Act of 1933, you are hereby advised that Schaeffer's Investment Research, Inc. "Schaeffer's" is receiving a fee of over $1000.00 in cash, from an independent third party as compensation for the distribution of this advertisement. Schaeffer's has not determined if the statements and opinions of the advertiser are accurate, correct or truthful. The purpose of this advertisement, like any advertising, is to provide publicity for the advertising company, its products or services. You should not rely on the information presented; you should do independent research to form your own opinion and decision. Information contained in our disseminated emails does not constitute investment, legal or tax advice upon which you should rely. The purchase of high-risk securities may result in the loss of your entire investment. Advertisements received by you are not a solicitation or recommendation to buy securities of the advertised company. An offer to buy or sell securities can be made only by a disclosure document that complies with applicable securities laws and only in the States or other jurisdictions in which the security is eligible for sale. Advertisements distributed through disseminated emails are not disclosure documents. If you are considering purchasing any securities of an advertised company, you should call your State Securities Administrator to determine if the security may be sold in your State. Many companies have information filed with State securities regulators who may be able to supply you with additional information. You also should read and review, if and to the extent available, any information concerning an advertised company available at the websites of the U.S. Securities and Exchange Commission (the "SEC") and the Financial Industry Regulatory Authority (the "FINRA"). We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud on the SEC website, as well as related information published by the NASD on how to invest carefully. You are responsible for verifying all claims and conducting your own due diligence. You agree and acknowledge that any hyperlinks to the website of (1) an advertised company, (2) the party issuing or preparing the information for the advertised company, or (3) other information contained in our disseminated emails is provided only for your reference and convenience. We are not responsible for the accuracy or reliability of these external sites, nor are we responsible for the content, advertising, opinions, products or other materials on external sites or information sources. If you use, act upon or make decisions in reliance on information contained in any disseminated email or any hyperlink, you do so at your own risk and agree to hold us, our officers, directors, shareholders, affiliates and agents harmless. You acknowledge that you are not relying on us, and we are not liable for, any actions taken by you based on any information contained in any disseminated email or hyperlink. You also acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser. You acknowledge that you will consult with your own advisers regarding any decisions as to any advertised company. Schaeffer's Investment Research 5151 Pfeiffer Road, Suite 250 Cincinnati, Ohio 45242